Australian Pharmacist

Pfizer’s Comirnaty COVID-19 vaccine has been provisionally approved by the Therapeutic Goods Administration (TGA) for use as a booster in those aged 16–17 years.

Changes to the Opioid Dependence Treatment program could make long-acting injectable buprenorphine the best option for many people.

Chlamydia and gonorrhoea are two of the most prevalent bacterial sexually transmitted infections (STIs) globally.

Compounding environments must be designed to minimise contamination risk —  including keeping meal breaks well away from the bench.

In a move aimed at reducing antibiotic resistance, the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended that four of the most widely prescribed antibiotics...

New research has explored the benefits of pharmacists joining allied health teams in Australian residential care facilities, with promising results. Australian Pharmacist spoke with Nicole...